These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 25373143)

  • 41. ALU A-to-I RNA Editing: Millions of Sites and Many Open Questions.
    Schaffer AA; Levanon EY
    Methods Mol Biol; 2021; 2181():149-162. PubMed ID: 32729079
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modulation of microRNA processing and expression through RNA editing by ADAR deaminases.
    Yang W; Chendrimada TP; Wang Q; Higuchi M; Seeburg PH; Shiekhattar R; Nishikura K
    Nat Struct Mol Biol; 2006 Jan; 13(1):13-21. PubMed ID: 16369484
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Altered editing in RNA editing adenosine deaminase ADAR2 gene transcripts of systemic lupus erythematosus T lymphocytes.
    Laxminarayana D; O'Rourke KS; Maas S; Olorenshaw I
    Immunology; 2007 Jul; 121(3):359-69. PubMed ID: 17376196
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Artificial RNA Editing with ADAR for Gene Therapy.
    Bhakta S; Tsukahara T
    Curr Gene Ther; 2020; 20(1):44-54. PubMed ID: 32416688
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In cancer, A-to-I RNA editing can be the driver, the passenger, or the mechanic.
    Ganem NS; Ben-Asher N; Lamm AT
    Drug Resist Updat; 2017 May; 32():16-22. PubMed ID: 29145975
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Positive correlation between ADAR expression and its targets suggests a complex regulation mediated by RNA editing in the human brain.
    Liscovitch N; Bazak L; Levanon EY; Chechik G
    RNA Biol; 2014; 11(11):1447-56. PubMed ID: 25692240
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biochemical and Transcriptome-Wide Identification of A-to-I RNA Editing Sites by ICE-Seq.
    Okada S; Sakurai M; Ueda H; Suzuki T
    Methods Enzymol; 2015; 560():331-53. PubMed ID: 26253977
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genome-wide identification and analysis of A-to-I RNA editing events in bovine by transcriptome sequencing.
    Bakhtiarizadeh MR; Salehi A; Rivera RM
    PLoS One; 2018; 13(2):e0193316. PubMed ID: 29470549
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Global regulation of alternative splicing by adenosine deaminase acting on RNA (ADAR).
    Solomon O; Oren S; Safran M; Deshet-Unger N; Akiva P; Jacob-Hirsch J; Cesarkas K; Kabesa R; Amariglio N; Unger R; Rechavi G; Eyal E
    RNA; 2013 May; 19(5):591-604. PubMed ID: 23474544
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genome-wide A-to-I RNA editing in fungi independent of ADAR enzymes.
    Liu H; Wang Q; He Y; Chen L; Hao C; Jiang C; Li Y; Dai Y; Kang Z; Xu JR
    Genome Res; 2016 Apr; 26(4):499-509. PubMed ID: 26934920
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A-to-I RNA editing - thinking beyond the single nucleotide.
    Ganem NS; Lamm AT
    RNA Biol; 2017 Dec; 14(12):1690-1694. PubMed ID: 28820319
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ADBP-1 regulates ADR-2 nuclear localization to control editing substrate selection.
    Eliad B; Schneider N; Zgayer OB; Amichan Y; Glaser F; Erdmann EA; Rajendren S; Hundley HA; Lamm AT
    bioRxiv; 2024 Jun; ():. PubMed ID: 38895382
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Base-pairing probability in the microRNA stem region affects the binding and editing specificity of human A-to-I editing enzymes ADAR1-p110 and ADAR2.
    Ishiguro S; Galipon J; Ishii R; Suzuki Y; Kondo S; Okada-Hatakeyama M; Tomita M; Ui-Tei K
    RNA Biol; 2018; 15(7):976-989. PubMed ID: 29950133
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genome-wide quantification of ADAR adenosine-to-inosine RNA editing activity.
    Roth SH; Levanon EY; Eisenberg E
    Nat Methods; 2019 Nov; 16(11):1131-1138. PubMed ID: 31636457
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Loss of circRNAs from the crh-1 gene extends the mean lifespan in Caenorhabditis elegans.
    Knupp D; Jorgensen BG; Alshareef HZ; Bhat JM; Grubbs JJ; Miura P; van der Linden AM
    Aging Cell; 2022 Feb; 21(2):e13560. PubMed ID: 35102684
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ADARs, RNA editing and more in hematological malignancies.
    Teoh PJ; Koh MY; Chng WJ
    Leukemia; 2021 Feb; 35(2):346-359. PubMed ID: 33139858
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Computational approaches for detection and quantification of A-to-I RNA-editing.
    Pinto Y; Levanon EY
    Methods; 2019 Mar; 156():25-31. PubMed ID: 30465820
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Developmental atlas of the RNA editome in Sus scrofa skeletal muscle.
    Yang Y; Zhu M; Fan X; Yao Y; Yan J; Tang Y; Liu S; Li K; Tang Z
    DNA Res; 2019 Jun; 26(3):261-272. PubMed ID: 31231762
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ADAR editing in double-stranded UTRs and other noncoding RNA sequences.
    Hundley HA; Bass BL
    Trends Biochem Sci; 2010 Jul; 35(7):377-83. PubMed ID: 20382028
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prediction of constitutive A-to-I editing sites from human transcriptomes in the absence of genomic sequences.
    Zhu S; Xiang JF; Chen T; Chen LL; Yang L
    BMC Genomics; 2013 Mar; 14():206. PubMed ID: 23537002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.